CN101353383B - Water-soluble yeast beta-dextran and preparation thereof - Google Patents
Water-soluble yeast beta-dextran and preparation thereof Download PDFInfo
- Publication number
- CN101353383B CN101353383B CN2008101402143A CN200810140214A CN101353383B CN 101353383 B CN101353383 B CN 101353383B CN 2008101402143 A CN2008101402143 A CN 2008101402143A CN 200810140214 A CN200810140214 A CN 200810140214A CN 101353383 B CN101353383 B CN 101353383B
- Authority
- CN
- China
- Prior art keywords
- dextran
- water
- beta
- soluble
- alkaline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920002307 Dextran Polymers 0.000 title claims abstract description 111
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims description 115
- 239000003513 alkali Substances 0.000 claims abstract description 27
- 238000000605 extraction Methods 0.000 claims abstract description 15
- 238000012545 processing Methods 0.000 claims abstract description 10
- 238000001556 precipitation Methods 0.000 claims description 55
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 47
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 39
- 239000007788 liquid Substances 0.000 claims description 28
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 13
- 238000000746 purification Methods 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 238000004440 column chromatography Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 230000035484 reaction time Effects 0.000 claims description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 239000012670 alkaline solution Substances 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 235000017550 sodium carbonate Nutrition 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 8
- 238000009156 water cure Methods 0.000 claims description 8
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 6
- 108091005804 Peptidases Proteins 0.000 claims description 6
- 102000035195 Peptidases Human genes 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 4
- 238000006386 neutralization reaction Methods 0.000 claims description 4
- 108090000145 Bacillolysin Proteins 0.000 claims description 3
- 229920002271 DEAE-Sepharose Polymers 0.000 claims description 3
- 102000035092 Neutral proteases Human genes 0.000 claims description 3
- 108091005507 Neutral proteases Proteins 0.000 claims description 3
- 239000012564 Q sepharose fast flow resin Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000010612 desalination reaction Methods 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 239000012501 chromatography medium Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 27
- 230000000242 pagocytic effect Effects 0.000 abstract description 5
- 238000003809 water extraction Methods 0.000 abstract description 5
- 239000012535 impurity Substances 0.000 abstract description 3
- 235000013365 dairy product Nutrition 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 210000002540 macrophage Anatomy 0.000 abstract description 2
- 235000019543 dairy drink Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005934 immune activation Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 29
- 239000000243 solution Substances 0.000 description 24
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 19
- 229920002498 Beta-glucan Polymers 0.000 description 19
- 230000008569 process Effects 0.000 description 18
- 150000004676 glycans Chemical class 0.000 description 11
- 239000012510 hollow fiber Substances 0.000 description 10
- 229920001282 polysaccharide Polymers 0.000 description 10
- 239000005017 polysaccharide Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000000108 ultra-filtration Methods 0.000 description 9
- 239000000523 sample Substances 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 229960004756 ethanol Drugs 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 235000014666 liquid concentrate Nutrition 0.000 description 5
- 238000001471 micro-filtration Methods 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229920001503 Glucan Polymers 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 102000011759 adducin Human genes 0.000 description 4
- 108010076723 adducin Proteins 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229960001031 glucose Drugs 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000002516 radical scavenger Substances 0.000 description 4
- 229920000392 Zymosan Polymers 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000000367 immunologic factor Substances 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003214 pyranose derivatives Chemical group 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- 102100024023 Histone PARylation factor 1 Human genes 0.000 description 2
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical class OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 108010005335 mannoproteins Proteins 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 101000874334 Dalbergia nigrescens Isoflavonoid 7-O-beta-apiosyl-glucoside beta-glycosidase Proteins 0.000 description 1
- 101000757733 Enterococcus faecalis (strain ATCC 700802 / V583) Autolysin Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- LAZPBGZRMVRFKY-HNCPQSOCSA-N Levamisole hydrochloride Chemical compound Cl.C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 LAZPBGZRMVRFKY-HNCPQSOCSA-N 0.000 description 1
- 101000757734 Mycolicibacterium phlei 38 kDa autolysin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- SRBFZHDQGSBBOR-QMKXCQHVSA-N alpha-L-arabinopyranose Chemical compound O[C@H]1CO[C@@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-QMKXCQHVSA-N 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960002246 beta-d-glucopyranose Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 102000023852 carbohydrate binding proteins Human genes 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229960003734 levamisole hydrochloride Drugs 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101402143A CN101353383B (en) | 2008-09-17 | 2008-09-17 | Water-soluble yeast beta-dextran and preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101402143A CN101353383B (en) | 2008-09-17 | 2008-09-17 | Water-soluble yeast beta-dextran and preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101353383A CN101353383A (en) | 2009-01-28 |
CN101353383B true CN101353383B (en) | 2010-12-08 |
Family
ID=40306421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101402143A Active CN101353383B (en) | 2008-09-17 | 2008-09-17 | Water-soluble yeast beta-dextran and preparation thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101353383B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA201291091A1 (en) * | 2010-05-14 | 2013-05-30 | Олтек, Инк. | COMPONENTS OF THE CELLWALL OF THE YEAST AND THEIR DETECTION |
US20110293784A1 (en) | 2010-05-28 | 2011-12-01 | Anja Wittke | Milk-based nutritional compositions |
GB201020191D0 (en) * | 2010-11-29 | 2011-01-12 | Biotec Pharmacon Asa | Glucan gels |
CN102838688B (en) * | 2012-09-12 | 2014-07-30 | 江南大学 | Preparation method of soluble yeast glucan |
CN103059159B (en) * | 2013-02-01 | 2015-01-07 | 黄河三角洲京博化工研究院有限公司 | Process for extracting mannan from beer yeast powder |
CN103468765A (en) * | 2013-09-18 | 2013-12-25 | 陕西省微生物研究所 | Biological extracting and purifying method for beer yeast soluble 1,3-beta-D-glucan |
CN107148431A (en) * | 2014-10-31 | 2017-09-08 | 温特沙尔控股有限公司 | Method for concentrating beta glucan |
CN105001352B (en) * | 2015-07-14 | 2017-04-26 | 青岛海大海洋生物医药销售有限公司 | Beta-1,3/1,6-glucan, preparation method therefor, and application thereof in preparing immune enhancement and anti-tumor medicine and functional food |
CN106243239B (en) * | 2016-07-29 | 2018-11-27 | 山东大学齐鲁医院 | It is a kind of for improving the soluble small molecule beta-1,3-dextran of hepatitis immunity |
CN108611385A (en) * | 2016-12-12 | 2018-10-02 | 安琪酵母股份有限公司 | Water-soluble yeast beta-dextran and its preparation method and application |
CN106755196A (en) * | 2016-12-20 | 2017-05-31 | 广东工业大学 | One kind improves the water miscible method of beta glucan |
CN111011609A (en) * | 2019-12-24 | 2020-04-17 | 仙乐健康科技(安徽)有限公司 | A composition for enhancing immunity of mammals |
CN114304353B (en) * | 2021-12-30 | 2023-09-19 | 艾苛密(上海)健康科技股份有限公司 | Beta-glucan candy tablet with blood glucose and blood pressure reducing health care function and preparation method thereof |
CN114343045B (en) * | 2022-01-20 | 2023-11-17 | 河南省寓生堂食养科技有限公司 | Health care tabletting candy and preparation method thereof |
CN115590787B (en) * | 2022-10-13 | 2023-12-26 | 湖南天根乐微君科技有限公司 | Composition for acne removal and skin repair as well as preparation method and application thereof |
CN115975069A (en) * | 2023-01-04 | 2023-04-18 | 河南大学 | High-purity water-soluble yeast beta-glucan and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532223A (en) * | 1989-09-08 | 1996-07-02 | Alpha-Beta Technology, Inc. | Use of aqueous soluble glucan preparations to stimulate platelet production |
CN101117357A (en) * | 2007-09-17 | 2008-02-06 | 中国农业大学 | Method for preparing water-soluble beta-1,3/1,6-dextran |
-
2008
- 2008-09-17 CN CN2008101402143A patent/CN101353383B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532223A (en) * | 1989-09-08 | 1996-07-02 | Alpha-Beta Technology, Inc. | Use of aqueous soluble glucan preparations to stimulate platelet production |
CN101117357A (en) * | 2007-09-17 | 2008-02-06 | 中国农业大学 | Method for preparing water-soluble beta-1,3/1,6-dextran |
Non-Patent Citations (2)
Title |
---|
David L. Williams,et al..A method for the solubilization of a (1→3)-β-D-glucan isolated from Saccharomyces cerevisiae.Carbohydrate Research.1991,219 * |
李春林.灰树花水溶性β-葡聚糖的制备和结构研究.中国优秀博硕士学位论文全文数据库(硕士)工程科技I辑.2005,(1), * |
Also Published As
Publication number | Publication date |
---|---|
CN101353383A (en) | 2009-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101353383B (en) | Water-soluble yeast beta-dextran and preparation thereof | |
CN104450844B (en) | A kind of method and application thereof of extracting various active nutritive ingredient from Holothurian machining liquid | |
JP4420470B2 (en) | Abalone polysaccharide extraction method | |
CN101297821B (en) | Phellinus linteus mycelia active glucoprotein and use thereof and preparation | |
CN102524698B (en) | Method for preparing pumpkin dietary fiber | |
CN105001352B (en) | Beta-1,3/1,6-glucan, preparation method therefor, and application thereof in preparing immune enhancement and anti-tumor medicine and functional food | |
CN102224879B (en) | Preparation method and application of champignon polypeptide | |
CN103923201B (en) | A kind of preparation method of Hippocampus active glucoprotein | |
US10835552B2 (en) | Method for preparing linseed polysaccharide having antiviral activity and immunological activity, and use of the linseed polysaccharide | |
WO2022067774A1 (en) | Preparation method and application of sea cucumber polysaccharide | |
CN109608557A (en) | Polysaccharides extracts Isolation and purification method, Lycium chinense glycopeptide and preparation method | |
CN103848921A (en) | Lyceum ruthenicum alkali-extracted polysaccharide and preparation method and application thereof | |
CN116042342A (en) | Ginseng juice wine and production process thereof | |
CN110128489A (en) | A method of galactomannan oligosaccharide is prepared from hydrolysis | |
CN105777921A (en) | Astragalus polysaccharide extraction process and application thereof | |
CN102050882B (en) | Longan proteoglycan as well as preparation method and application thereof | |
CN104004109B (en) | Ocean Sulfation glycosaminoglycans SE-3 and preparation method thereof | |
CN107190039A (en) | A kind of preparation method of maize oligopeptide health products | |
CN108261418B (en) | Preparation and drying method of pachyman powder | |
CN106589154B (en) | A kind of preparation method of open country watermelon selenium polysaccharide | |
CN101220101A (en) | Trichoderma pseudokoningii exocellular polysaccharide, preparation method and application thereof | |
CN114129647B (en) | Oral liquid and preparation method thereof | |
CN106977592A (en) | A kind of method for isolating and purifying Agricus blazei fructification activated protein | |
CN109548951A (en) | The extracting method of quinoa bran protein and its application in terms of food | |
CN109575152A (en) | The method of efficient fast eliminating albumen and pigment from acanthopanax giraldii harms polysaccharose extracting solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHANDONG CHAMBROAD HOLDING CO., LTD. Free format text: FORMER NAME: SHANDONG JINGBO HOLDING DEVELOPMENT CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 256500 Shandong city of Binzhou province Hu Zhen Boxing County Chen Jingbo Industrial Park Patentee after: Shandong Chambroad Holding Co., Ltd. Address before: 256500 Binzhou, Shandong Province Jing Bo Industrial Park, Boxing Patentee before: Shandong Jingbo Holding Development Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: SHANDONG EFIRM BIOCHEMISTRY AND ENVIRONMENTAL PROT Free format text: FORMER OWNER: SHANDONG CHAMBROAD HOLDING CO., LTD. Effective date: 20110830 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20110830 Address after: 256500 Boxing Economic Development Zone, Binzhou, Shandong Patentee after: Shandong Efirm Biochemistry and Environmental Protection Co., Ltd. Address before: 256500 Shandong city of Binzhou province Hu Zhen Boxing County Chen Jingbo Industrial Park Patentee before: Shandong Chambroad Holding Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170324 Address after: 256500 Boxing Economic Development Zone, Shandong, Binzhou Patentee after: Yellow River Delta Jingbo Chemical Research Institute Co., Ltd. Address before: 256500 Boxing Economic Development Zone, Binzhou, Shandong Patentee before: Shandong Efirm Biochemistry and Environmental Protection Co., Ltd. |
|
TR01 | Transfer of patent right |